# Safety and Immunogenicity of a Zoster Vaccine in SLE

> **NCT02477150** · PHASE4 · COMPLETED · sponsor: **Tuen Mun Hospital** · enrollment: 90 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **BIOLOGICAL:** Zostavax
- **BIOLOGICAL:** placebo

## Key facts

- **NCT ID:** NCT02477150
- **Lead sponsor:** Tuen Mun Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2018-11
- **Final completion:** 2019-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2019-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02477150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02477150, "Safety and Immunogenicity of a Zoster Vaccine in SLE". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02477150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*